Skip to main content
Past Event

A conversation with CMS Administrator Seema Verma

An event from the USC-Brookings Schaeffer Initiative for Health Policy

Past Event

Keynote remarks and conversation

Today, 43 million Americans have prescription drug coverage through Medicare Part D, roughly double the number since the program’s introduction in 2006. In the wake of fast-growing drug prices and the rise of specialty drugs, renewed attention has focused on reforming Part D’s benefit structure and providing plans with more tools to obtain lower drug prices. The Trump administration has issued a series of recommendations in their “Blueprint to Lower Drug Prices” and the president’s budget, and the administration has already begun to advance several pricing reforms through regulation.

On October 18, the USC-Brookings Schaeffer Initiative for Health Policy hosted Seema Verma, the administrator of the Centers for Medicare and Medicaid Services, for a discussion about Medicare Part D and what can be done to improve the program. Following her presentation, Ms. Verma sat down with USC Schaeffer Center for Health Policy & Economics Director Dana Goldman for an interview. A panel of experts then discussed the administrator’s comments and related issues in the Medicare Part D program.

Agenda

Welcome and introduction

Leonard D. Schaeffer

Judge Robert Maclay Widney Chair and Professor - USC Schaeffer Center for Health Policy & Economics and USC Price School of Public Policy

Trustee - University of Southern California

Trustee - Brookings Institution

Keynote remarks

Conversation

Dana Goldman

Leonard D. Schaeffer Director's Chair - Schaeffer Center for Health Policy & Economics

Distinguished Professor of Public Policy, Pharmacy, & Economics - Sol Price School of Public Policy and USC School of Pharmacy

Nonresident Senior Fellow - Economic Studies, Center for Health Policy

Questions & answers

Panel discussion

Samuel Nussbaum

Former Chief Medical Officer - Anthem, Inc.

Quintiles Senior Fellow - USC Schaeffer Center

Clinical Professor - Washington University School of Medicine

Strategic Advisor - Epstein Becker Green

Stacie B. Dusetzina

Associate Professor, Health Policy, Ingram Associate Professor of Cancer Research - Vanderbilt University Medical Center

Geoffrey Joyce

Director of Health Policy - USC Schaeffer Center for Health Policy & Economics, University of Southern California

Chair of Pharmaceutical and Health Economics Department - USC School of Pharmacy

Associate Professor, Pharmaceutical Economics and Policy - USC School of Pharmacy

More Information

To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.

More

Get a weekly events calendar from Brookings